219 related articles for article (PubMed ID: 32063859)
1. Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin.
Zhang S; Zhou L; Zhang M; Wang Y; Wang M; Du J; Gu W; Kui F; Li J; Geng S; Du G
Front Pharmacol; 2019; 10():1658. PubMed ID: 32063859
[TBL] [Abstract][Full Text] [Related]
2. Emodin regulates neutrophil phenotypes to prevent hypercoagulation and lung carcinogenesis.
Li Z; Lin Y; Zhang S; Zhou L; Yan G; Wang Y; Zhang M; Wang M; Lin H; Tong Q; Duan Y; Du G
J Transl Med; 2019 Mar; 17(1):90. PubMed ID: 30885207
[TBL] [Abstract][Full Text] [Related]
3. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
[TBL] [Abstract][Full Text] [Related]
4. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
5. Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination.
Chen B; Zhang JP
Phytomedicine; 2022 Jul; 101():154130. PubMed ID: 35526324
[TBL] [Abstract][Full Text] [Related]
6. Berberine Alleviates Doxorubicin-Induced Myocardial Injury and Fibrosis by Eliminating Oxidative Stress and Mitochondrial Damage via Promoting Nrf-2 Pathway Activation.
Wang Y; Liao J; Luo Y; Li M; Su X; Yu B; Teng J; Wang H; Lv X
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834687
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Activity of Berberine by Activating Autophagy and Apoptosis in CAL-62 and BHT-101 Anaplastic Thyroid Carcinoma Cell Lines.
Shi XZ; Zhao S; Wang Y; Wang MY; Su SW; Wu YZ; Xiong C
Drug Des Devel Ther; 2023; 17():1889-1906. PubMed ID: 37397788
[TBL] [Abstract][Full Text] [Related]
8. Solid Lipid Nanoformulation of Berberine Attenuates Doxorubicin Triggered
Rawal S; Gupta P; Bhatnagar P; Yadav HN; Dinda AK
Comb Chem High Throughput Screen; 2022; 25(10):1695-1706. PubMed ID: 35718970
[TBL] [Abstract][Full Text] [Related]
9. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression.
Lv X; Yu X; Wang Y; Wang F; Li H; Wang Y; Lu D; Qi R; Wang H
PLoS One; 2012; 7(10):e47351. PubMed ID: 23077597
[TBL] [Abstract][Full Text] [Related]
10. Hyperoside alleviates doxorubicin-induced myocardial cells apoptosis by inhibiting the apoptosis signal-regulating kinase 1/p38 pathway.
Chen L; Qin Z; Ruan ZB
PeerJ; 2023; 11():e15315. PubMed ID: 37220525
[TBL] [Abstract][Full Text] [Related]
11. Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer.
Pan Y; Zhang F; Zhao Y; Shao D; Zheng X; Chen Y; He K; Li J; Chen L
J Cancer; 2017; 8(9):1679-1689. PubMed ID: 28775788
[TBL] [Abstract][Full Text] [Related]
12. Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts.
Coelho AR; Martins TR; Couto R; Deus C; Pereira CV; Simões RF; Rizvanov AA; Silva F; Cunha-Oliveira T; Oliveira PJ; Serafim TL
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2904-2923. PubMed ID: 28760703
[TBL] [Abstract][Full Text] [Related]
13. Retraction: Berberine maintains the neutrophil N1 phenotype to reverse cancer cell resistance to doxorubicin.
Frontiers Editorial Office
Front Pharmacol; 2023; 14():1349235. PubMed ID: 38130404
[TBL] [Abstract][Full Text] [Related]
14. Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway.
Wu YZ; Zhang L; Wu ZX; Shan TT; Xiong C
Oxid Med Cell Longev; 2019; 2019():2150394. PubMed ID: 31885776
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin resistance in breast cancer xenografts and cell lines can be counterweighted by microRNA-140-3p, through PD-L1 suppression.
Zhang X; Wang C; Huang C; Yang J; Wang J
Histol Histopathol; 2023 Oct; 38(10):1193-1204. PubMed ID: 36621840
[TBL] [Abstract][Full Text] [Related]
16. N,N-Dimethyl phytosphingosine sensitizes HL-60/MX2, a multidrug-resistant variant of HL-60 cells, to doxorubicin-induced cytotoxicity through ROS-mediated release of cytochrome c and AIF.
Kim BM; Choi YJ; Lee YH; Joe YA; Hong SH
Apoptosis; 2010 Aug; 15(8):982-93. PubMed ID: 20512627
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice.
Yahuafai J; Asai T; Oku N; Siripong P
Biol Pharm Bull; 2018; 41(7):1103-1106. PubMed ID: 29962406
[TBL] [Abstract][Full Text] [Related]
18. Aidi injection enhances the anti-tumor impact of doxorubicin in H22 tumor-containing mice.
Lu Y; Zhang S; Zhu X; Wang K; He Y; Liu C; Sun J; Pan J; Zheng L; Liu W; Li Y; Huang Y; Liu T
J Ethnopharmacol; 2023 Mar; 303():115968. PubMed ID: 36473617
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma.
Deng H; Kan A; Lyu N; He M; Huang X; Qiao S; Li S; Lu W; Xie Q; Chen H; Lai J; Chen Q; Jiang X; Liu S; Zhang Z; Zhao M
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34168004
[TBL] [Abstract][Full Text] [Related]
20. Low‑intensity ultrasound enhances the antitumor effects of doxorubicin on hepatocellular carcinoma cells through the ROS‑miR‑21‑PTEN axis.
Xia C; Zeng H; Zheng Y
Mol Med Rep; 2020 Mar; 21(3):989-998. PubMed ID: 32016465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
